Tarka 180/2


Prolonged-release tablets
scheduling status
S3
registration number
A39/7.1.3/0508
What Tarka 180/2 contains
Each tablet contains 180 mg verapamil hydrochloride in a sustained release form and 2 mg trandolapril.
other ingredients
Inactive ingredients include the following: anhydrous silica, black ferric oxide, docusate sodium, hydroxypropylcellulose, hypromellose, lactose monohydrate, macrogol, magnesium stearate, maize starch, microcrystalline cellulose, povidone, red ferric oxide, sodium alginate, sodium, stearyl fumarate, talc, titanium dioxide, and yellow ferric oxide.
Therapeutic classification
C09BB10.
© 2026 SAHPRA. ALL RIGHTS RESERVED